HomeNewsScreenerChartsMapsGroupsPortfolioInsiderFuturesForexCryptoCalendarPricing
Theme 		Help

New Elite Feature: Screen & Chart at the same time

Learn More
Market News Market Pulse Stocks News ETF News Crypto News

Relay Therapeutics, Inc.

Contributing Author

Recent Articles by Relay Therapeutics, Inc.

May-05
Relay Therapeutics Reports First Quarter 2026 Financial Results and Corporate Updates RLAY GlobeNewswire
Apr-29
Relay Therapeutics to Announce First Quarter 2026 Financial Results and Corporate Highlights on May 5, 2026 RLAY GlobeNewswire
Apr-27
Relay Therapeutics Announces Clinical Data for Zovegalisib plus Atirmociclib Triplet Combination Supportive of Further Development in Frontline Metastatic Breast Cancer RLAY GlobeNewswire
Apr-02
Relay Therapeutics to Present Initial Clinical Data on Zovegalisib in Vascular Anomalies at the International Society for the Study of Vascular Anomalies World Congress 2026 RLAY +16.43% GlobeNewswire
Mar-16
Relay Therapeutics Announces Data from Zovegalisib + Fulvestrant at the Phase 3 Dose of 400mg BID Fed at ESMO Targeted Anticancer Therapies Congress 2026 RLAY GlobeNewswire
Feb-26
Relay Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Outlines Anticipated 2026 Milestones RLAY +12.01% RLAY GlobeNewswire
Feb-23
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in March RLAY GlobeNewswire
Feb-19
Relay Therapeutics to Announce Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights on February 26, 2026 RLAY GlobeNewswire
Feb-04
Relay Therapeutics to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026 RLAY GlobeNewswire
Feb-03
Relay Therapeutics Announces Zovegalisib Granted Breakthrough Therapy Designation by U.S. FDA for PIK3CA-mutant, HR+/HER2- Advanced Breast Cancer RLAY +6.38% GlobeNewswire
Dec-12
Relay Therapeutics Announces Efficacy Subset Analysis of Zovegalisib (RLY-2608) + Fulvestrant in Breast Cancer Patients Pre-Treated with SERD or with ESR1 Mutations at SABCS 2025 RLAY GlobeNewswire
Nov-06
Relay Therapeutics Reports Third Quarter 2025 Financial Results and Corporate Updates RLAY -7.35% RLAY GlobeNewswire
Nov-03
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in November RLAY GlobeNewswire
Oct-30
Relay Therapeutics to Announce Third Quarter 2025 Financial Results and Corporate Highlights on November 6, 2025 RLAY GlobeNewswire
Aug-28
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in September RLAY GlobeNewswire
Aug-07
Relay Therapeutics Reports Second Quarter 2025 Financial Results and Corporate Updates RLAY -7.74% RLAY GlobeNewswire
Jul-31
Relay Therapeutics to Announce Second Quarter 2025 Financial Results and Corporate Highlights on August 7, 2025 RLAY GlobeNewswire
Jun-11
Relay Therapeutics Appoints Claire Mazumdar, Ph.D., to Board of Directors RLAY GlobeNewswire
Jun-02
Relay Therapeutics Announces Updated Data for RLY-2608 + Fulvestrant Further Demonstrating Clinically Meaningful Progression Free Survival at ASCO 2025 RLAY +6.00% GlobeNewswire
May-29
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in June RLAY GlobeNewswire
May-08
Relay Therapeutics to Participate in Two Upcoming Investor Conferences RLAY GlobeNewswire
May-05
Relay Therapeutics Reports First Quarter 2025 Financial Results and Corporate Updates RLAY -5.12% RLAY GlobeNewswire
Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)